Higher risk of death and stroke in patients with persistent vs. paroxysmal atrial fibrillation: results from the ROCKET-AF Trial

AIM: Anticoagulation prophylaxis for stroke is recommended for at-risk patients with either persistent or paroxysmal atrial fibrillation (AF). We compared outcomes in patients with persistent vs. paroxysmal AF receiving oral anticoagulation. METHODS AND RESULTS: Patients randomized in the Rivaroxaba...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Eur Heart J
Hauptverfasser: Steinberg, Benjamin A., Hellkamp, Anne S., Lokhnygina, Yuliya, Patel, Manesh R., Breithardt, Günter, Hankey, Graeme J., Becker, Richard C., Singer, Daniel E., Halperin, Jonathan L., Hacke, Werner, Nessel, Christopher C., Berkowitz, Scott D., Mahaffey, Kenneth W., Fox, Keith A.A., Califf, Robert M., Piccini, Jonathan P.
Format: Artigo
Sprache:Inglês
Veröffentlicht: Oxford University Press 2015
Schlagworte:
Clinical Research
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4313363/
https://ncbi.nlm.nih.gov/pubmed/25209598
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/eurheartj/ehu359
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge